Literature DB >> 8045559

Mutation analysis of a Sandhoff disease patient in the Maronite community in Cyprus.

Y Hara1, P Ioannou, A Drousiotou, G Stylianidou, V Anastasiadou, K Suzuki.   

Abstract

Sandhoff disease occurs in the Christian Maronite community in Cyprus, a community that established over a thousand years ago. Nowadays, this community comprises less than 1% of the whole population, and has been culturally and socially isolated. Cultured fibroblasts from a patient from this inbred group showed a beta-hexosaminidase beta subunit mRNA of apparently the normal size but of reduced quantity. A mutational analysis of cDNA obtained by polymerase chain reaction amplification of mRNA showed a deletion of A at nt 76 (counted from A of the initiation codon, ATG). The deletion results in a frame shift and a premature termination within 20 amino acids from the N-terminus of the normal mature enzyme protein. The patient was homozygous for the deletion. The 5'-end of the gene showed many discrepancies from the previously published sequence. We consider that these differences are probably polymorphisms of little functional significance, because the patient's fibroblasts generate decreased but stable mRNA and because some of these base changes were also found in the genes from control fibroblasts. An extensive evaluation of the prevalence of this mutant allele in this community is being initiated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8045559     DOI: 10.1007/bf00202858

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  16 in total

1.  Characterization of the human HEXB gene encoding lysosomal beta-hexosaminidase.

Authors:  K Neote; B Bapat; A Dumbrille-Ross; C Troxel; S M Schuster; D J Mahuran; R A Gravel
Journal:  Genomics       Date:  1988-11       Impact factor: 5.736

2.  Isolation of cDNA clones coding for the alpha-subunit of human beta-hexosaminidase. Extensive homology between the alpha- and beta-subunits and studies on Tay-Sachs disease.

Authors:  R G Korneluk; D J Mahuran; K Neote; M H Klavins; B F O'Dowd; M Tropak; H F Willard; M J Anderson; J A Lowden; R A Gravel
Journal:  J Biol Chem       Date:  1986-06-25       Impact factor: 5.157

3.  The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase.

Authors:  R Myerowitz; F C Costigan
Journal:  J Biol Chem       Date:  1988-12-15       Impact factor: 5.157

4.  Structure and distribution of an Alu-type deletion mutation in Sandhoff disease.

Authors:  K Neote; B McInnes; D J Mahuran; R A Gravel
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

Review 5.  Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.

Authors:  K Suzuki; M T Vanier
Journal:  Dev Neurosci       Date:  1991       Impact factor: 2.984

6.  Molecular and clinical heterogeneity of adult GM2 gangliosidosis.

Authors:  R Navon
Journal:  Dev Neurosci       Date:  1991       Impact factor: 2.984

7.  Splice junction mutation in some Ashkenazi Jews with Tay-Sachs disease: evidence against a single defect within this ethnic group.

Authors:  R Myerowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  A splicing defect due to an exon-intron junctional mutation results in abnormal beta-hexosaminidase alpha chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs disease.

Authors:  K Ohno; K Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1988-05-31       Impact factor: 3.575

10.  Different mutations in Ashkenazi Jewish and non-Jewish French Canadians with Tay-Sachs disease.

Authors:  R Myerowitz; N D Hogikyan
Journal:  Science       Date:  1986-06-27       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.